Center on Democracy, Development, and the Rule of Law
Center for International Security and Cooperation
Stanford Health Policy
Walter H. Shorenstein Asia-Pacific Research Center
Forum on Contemporary Europe
Program on Energy and Sustainable Development
Program on Food Security and the Environment
Stanford Program on International and Cross-Cultural Education
Inter-University Center for Japanese Language Studies
CHP/PCOR Publications
ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: a Report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of Performance Measurement and Reperfusion Therapy)
CommentaryAuthors
Masoudi FA, Benow RO, Brindis RG, Cannon CP, Debuhr J, Fitzgerald S, Paul A. Heidenreich, Ho KK, Krumholz HM, Leber C, Magid DJ, Nilasena DS, Rumsfeld JS, Smith SC, Wharton TP
Published by
Journal of the American College of Cardiology, Vol. 52 no. 24, page(s) 2100-12
Dec 9, 2008
Acute reperfusion therapy, either with fibrinolytic therapy or percutaneous coronary intervention (PCI), is one of the most important treatments for patients with ST-segment elevation myocardial infarction (STEMI). Randomized clinical trials have shown that reperfusion therapy provided to eligible patients reduces the risk of death due to all causes.
.jpg){kind=small}
RSS/XML feeds